Signet Financial Management’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Sell
5,933
-1,791
-23% -$371K 0.12% 154
2025
Q4
$2.05M Sell
7,724
-133
-2% -$33.1K 0.23% 118
2025
Q3
$1.86M Sell
7,857
-45
-0.6% -$11.3K 0.22% 125
2025
Q2
$2.15M Buy
7,902
+28
+0.4% +$7.49K 0.27% 116
2025
Q1
$2.11M Sell
7,874
-126
-2% -$39.2K 0.29% 115
2024
Q4
$2.67M Sell
8,000
-61
-0.8% -$19.5K 0.34% 92
2024
Q3
$2.21M Buy
8,061
+2,197
+37% +$563K 0.28% 111
2024
Q2
$1.51M Sell
5,864
-26
-0.4% -$6.96K 0.2% 128
2024
Q1
$1.77M Buy
5,890
+229
+4% +$66.1K 0.24% 124
2023
Q4
$1.49M Buy
+5,661
New +$1.28M 0.22% 129
2022
Q1
Sell
-657
Closed -$167K 460
2021
Q4
$167K Buy
+657
New +$185K 0.03% 268
2018
Q4
Sell
-17
Closed -$3K 352
2018
Q3
$3K Hold
17
﹤0.01% 862
2018
Q2
$2K Hold
17
﹤0.01% 808
2018
Q1
$2K Buy
+17
New +$1.95K ﹤0.01% 742

Other funds holding CRM

Signet Financial Management's CRM Position: Q1 2026 in Review

Signet Financial Management reduced its Salesforce (CRM) stake by 23% in Q1 2026, selling an estimated $371K and leaving 5,933 shares worth $1.11M. The position accounts for 0.12% of the portfolio, ranked #154.

Signet Financial Management first reported a position in CRM in Q1 2018 and has held it in 14 quarters since. The position peaked at $2.67M in Q4 2024. 2,672 funds tracked by Wall St. Rank hold CRM as of Q1 2026.

  • Signet Financial Management held 5,933 shares of Salesforce worth $1.11M as of Q1 2026.
  • Signet Financial Management sold 1,791 Salesforce shares in Q1 2026, an estimated $371K.
  • Salesforce made up 0.12% of Signet Financial Management's portfolio in Q1 2026, its #154 holding.
  • Signet Financial Management first reported a position in Salesforce in Q1 2018 and has held it in 14 quarters since.
  • Signet Financial Management's Salesforce position peaked at $2.67M in Q4 2024.
  • 2,672 funds tracked by Wall St. Rank held Salesforce as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.